Skip to Main Content

Author Details

Sven Bilke
Center for Cancer Research, National Cancer Institute, National Institutes of Health
2001
53
30
PMIDPaper TitleJournal TitlePublished Year
33166276The interplay between cancer type, panel size and tumor mutational burden threshold in patient selection for cancer immunotherapy.PLoS Comput Biol2020
32079537Author Correction: Interaction between the microbiome and TP53 in human lung cancer.Genome Biol2020
33166276The interplay between cancer type, panel size and tumor mutational burden threshold in patient selection for cancer immunotherapy.PLoS Comput Biol2020
32079537Author Correction: Interaction between the microbiome and TP53 in human lung cancer.Genome Biol2020
30143034Interaction between the microbiome and TP53 in human lung cancer.Genome Biol2018
30012561A Genome-Wide Screen Reveals a Role for the HIR Histone Chaperone Complex in Preventing Mislocalization of Budding Yeast CENP-A.Genetics2018
30143034Interaction between the microbiome and TP53 in human lung cancer.Genome Biol2018
30012561A Genome-Wide Screen Reveals a Role for the HIR Histone Chaperone Complex in Preventing Mislocalization of Budding Yeast CENP-A.Genetics2018
29296821Progenitor B-1 B-cell acute lymphoblastic leukemia is associated with collaborative mutations in 3 critical pathways.Blood Adv2017
29296821Progenitor B-1 B-cell acute lymphoblastic leukemia is associated with collaborative mutations in 3 critical pathways.Blood Adv2017
28196408Somatic mutations in murine models of leukemia and lymphoma: Disease specificity and clinical relevance.Genes Chromosomes Cancer2017
28196408Somatic mutations in murine models of leukemia and lymphoma: Disease specificity and clinical relevance.Genes Chromosomes Cancer2017
24662829A mutant p53/let-7i-axis-regulated gene network drives cell migration, invasion and metastasis.Oncogene2015
25712098EWS-FLI1 employs an E2F switch to drive target gene expression.Nucleic Acids Res2015
25779942SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma.Clin Cancer Res2015
25775580The CDX1-microRNA-215 axis regulates colorectal cancer stem cell differentiation.Proc Natl Acad Sci U S A2015
24662829A mutant p53/let-7i-axis-regulated gene network drives cell migration, invasion and metastasis.Oncogene2015
25712098EWS-FLI1 employs an E2F switch to drive target gene expression.Nucleic Acids Res2015
25779942SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma.Clin Cancer Res2015
25775580The CDX1-microRNA-215 axis regulates colorectal cancer stem cell differentiation.Proc Natl Acad Sci U S A2015
24277930A p21-ZEB1 complex inhibits epithelial-mesenchymal transition through the microRNA 183-96-182 cluster.Mol Cell Biol2014
25404939Replicon: a software to accurately predict DNA replication timing in metazoan cells.Front Genet2014
25483193Identification of RECQ1-regulated transcriptome uncovers a role of RECQ1 in regulation of cancer cell migration and invasion.Cell Cycle2014
24277930A p21-ZEB1 complex inhibits epithelial-mesenchymal transition through the microRNA 183-96-182 cluster.Mol Cell Biol2014
24682507A chromatin structure-based model accurately predicts DNA replication timing in human cells.Mol Syst Biol2014
24535671NUP98-PHF23 is a chromatin-modifying oncoprotein that causes a wide array of leukemias sensitive to inhibition of PHD histone reader function.Cancer Discov2014
24974848A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors.Nat Genet2014
24653980Evidence for a Functional Link between Chromosomal Breakpoints and Aberrant DNA Methylation in Cancer.Front Oncol2014
25483193Identification of RECQ1-regulated transcriptome uncovers a role of RECQ1 in regulation of cancer cell migration and invasion.Cell Cycle2014
25404939Replicon: a software to accurately predict DNA replication timing in metazoan cells.Front Genet2014
24974848A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors.Nat Genet2014
24535671NUP98-PHF23 is a chromatin-modifying oncoprotein that causes a wide array of leukemias sensitive to inhibition of PHD histone reader function.Cancer Discov2014
24682507A chromatin structure-based model accurately predicts DNA replication timing in human cells.Mol Syst Biol2014
24653980Evidence for a Functional Link between Chromosomal Breakpoints and Aberrant DNA Methylation in Cancer.Front Oncol2014
23385593Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer.Nat Commun2013
23856246The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology.Cancer Res2013
23940108Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer.Genome Res2013
24491168104th American Association For Cancer Research (AACR) annual meeting; breakthroughs in science and technology changing cancer care.ACS Chem Biol2013
23385593Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer.Nat Commun2013
24491168104th American Association For Cancer Research (AACR) annual meeting; breakthroughs in science and technology changing cancer care.ACS Chem Biol2013
23856246The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology.Cancer Res2013
23940108Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer.Genome Res2013
22081342Genome-wide methylation profiling in archival formalin-fixed paraffin-embedded tissue samples.Methods Mol Biol2012
22723554Enforced expression of Lin28b leads to impaired T-cell development, release of inflammatory cytokines, and peripheral T-cell lymphoma.Blood2012
23138295Analyzing the association of SCNA boundaries with replication timing.Nat Biotechnol2012
22081342Genome-wide methylation profiling in archival formalin-fixed paraffin-embedded tissue samples.Methods Mol Biol2012
23138295Analyzing the association of SCNA boundaries with replication timing.Nat Biotechnol2012
22723554Enforced expression of Lin28b leads to impaired T-cell development, release of inflammatory cytokines, and peripheral T-cell lymphoma.Blood2012
21641572A methyl-deviator epigenotype of estrogen receptor-positive breast carcinoma is associated with malignant biology.Am J Pathol2011
21813623Genome-wide depletion of replication initiation events in highly transcribed regions.Genome Res2011
  • 1 - 50 of 106

Recommended Authors

University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 2
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 9
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 1
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 3
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 1
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 2
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 5
Harvard Medical School
Career Start Year 2001
Number of shared co-authors 2
University of Virginia
Career Start Year 2000
Number of shared co-authors 0
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 0
Stanford Center for Biomedical Informatics Research, Stanford University
Career Start Year 1999
Number of shared co-authors 0
Institute for Translational Epigenetics, University of Cologne
Career Start Year 1999
Number of shared co-authors 0
Genentech Inc.
Career Start Year 1999
Number of shared co-authors 0
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 5
University of Oslo
Career Start Year 1997
Number of shared co-authors 2
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 2
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 1
German Cancer Research Center (DKFZ)
Career Start Year 1993
Number of shared co-authors 0
University of British Columbia
Career Start Year 1993
Number of shared co-authors 2
University of British Columbia
Career Start Year 1993
Number of shared co-authors 7
Cancer Center Amsterdam, Vrije Universiteit Amsterdam
Career Start Year 1992
Number of shared co-authors 1
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 4
University of California San Diego
Career Start Year 1988
Number of shared co-authors 2
Center for Bioinformatics, University of Oslo
Career Start Year 1987
Number of shared co-authors 2
Stanford University School of Medicine
Career Start Year 1987
Number of shared co-authors 3
British Columbia Cancer Research Institute
Career Start Year 1987
Number of shared co-authors 3
German Cancer Research Center (DKFZ)
Career Start Year 1986
Number of shared co-authors 1
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 11
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 6

Collaborators

Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 25
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 16
Center for Cancer Research, National Cancer Institute
Co-authored papers 13
Center for Cancer Research, National Cancer Institute
Co-authored papers 13
Center for Biomedical Informatics and Information Technology
Co-authored papers 11
National Cancer Institute, National Institutes of Health
Co-authored papers 10
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 9
Co-authored papers 9
Center for Cancer Research, National Cancer Institute
Co-authored papers 8
Kansas State University
Co-authored papers 6
Inc.Foster CityCA.
Co-authored papers 5
West China Second Hospital, Sichuan University
Co-authored papers 5
National Cancer Institute
Co-authored papers 5
From Foundation Medicine
Co-authored papers 5
Co-authored papers 4
Suburban Hospital Department of Pathology
Co-authored papers 4
International Food Policy Research Institute
Co-authored papers 4
Zhujiang Hospital, Southern Medical University
Co-authored papers 4
Lund University, Linkoping University. .
Co-authored papers 3
Institute of Bioscience and Integrative Medicine, Daejeon University
Co-authored papers 3
National Cancer Institute, Center for Cancer Research
Co-authored papers 3
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
Meharry Medical College
Co-authored papers 3
University of Virginia
Co-authored papers 3
Mayo Clinic
Co-authored papers 3
St. Anna Children's Cancer Research Institute (CCRI)
Co-authored papers 2
Co-authored papers 2
Nanfang Hospital and Basic Medical College, Southern Medical University
Co-authored papers 2
Illumina Inc.
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2